BRAF and malignant colon neoplasm: The three patients who achieved CR included one MSS colon cancer patient, one MSS gastric cancer patient and one driver gene negative (wide type for EGFR, ALK, ROS1, and BRAF) NSCLC patient with PD-L1 combined positive score (CPS) of 30.